The Ulysses Genome Project: An Inclusive Mediterranean Genome Reference Of 100,000 Individuals
Leading DNA sequencing company Dante Labs has announced its
new Mediterranean Genome Project, Ulysses, which will sequence 100,000 human
whole genomes in the next...
ImmunoQure And Memo Therapeutics Collaborate To Biobank Rare Disease Autoantibodies
ImmunoQure AG, a biotechnology company focused on the
development of autoantibodies as therapeutics to treat human diseases and Memo
Therapeutics AG, a biotechnology company...
Owlstone Medical Joins 3TR To Provide Breath Biopsy Infrastructure And Analysis For Multiple Studies
Owlstone Medical, the global leader in Breath Biopsy® for
applications in early disease detection and precision medicine has joined 3TR,
a large-scale public-private research...
The Thailand CELS And PhenoMx Sign MOU With Potential Biobanking Projects
The Thailand Center of Excellence for Life Sciences (TCELS),
a public organisation, and PhenoMx, Inc., a US-based health technology company,
announced the execution of...
Biodesix Acquires Oncimmune’s US Based Laboratory Assets And IPN Malignancy Test
Biodesix, Inc., has completed acquisition of Oncimmune’s
laboratory and incidental pulmonary nodule (IPN) malignancy test in the United
States, further extending the company’s blood-based...
New Papers Discuss The Science And Ethics Of Human Brain Organoids
Research involving the transplantation of human “mini-brains”—known as brain organoids—into animals to study disease can provide crucial insight’s into disease. Medical ethicist’s...
4D Pharma And MSD Collaborate Leveraging The Microbiome To Develop Live Biotherapeutic Vaccines
4D pharma plc, a pharmaceutical company leading the
development of Live Biotherapeutics, has entered into a research collaboration
and option to license agreement with...
Cesca Therapeutics And HealthBanks Biotech (USA) Enter Immune Cell Banking And CDMO Joint Venture
Cesca Therapeutics Inc., a market leader in automated cell
processing and autologous cell therapies for regenerative medicine, and
ThermoGenesis, its wholly owned device subsidiary,...
Veracyte Makes Progress With Development Of Nasal Swab Test For Early Lung Cancer Detection
Veracyte, Inc. has announced preliminary clinical data
showing that the company’s non-invasive nasal swab test – the first of its kind
– can enable...
Crown Bioscience Teams Up With HUB To Launch Tumor Organoid Drug Development Platform
Crown Bioscience has launched a new tumor organoid drug
development platform with the potential to significantly improve the
predictivity and speed of preclinical drug...
New Patents Awarded To BioLife Solutions
BioLife Solutions, Inc., a leading developer and supplier of
best-in-class bioproduction tools for cell and gene therapies, has announced
the awarding of three new...
New England Biolabs® Launches Sequence-Based Genotyping For Agricultural Biotech Applications
New England Biolabs (NEB®) has launched the NEBNext Direct
Genotyping Solution, representing the first capture-based approach for
high-throughput genotyping for a wide variety of...
BC Platforms And Blueprint Genetics Partner To Enable Precision Medicine In Rare Diseases
BC Platforms, a world leader in genomic data management and
analytics, has formed a collaboration with Blueprint Genetics, a leader in the
field of...
MIMETAS And Hubrecht Organoid Technologies Partner To Market Organoids-On-A-Chip
MIMETAS and Hubrecht Organoid Technologies (HUB) have
entered into a strategic collaboration to market organoid models on a Chip. The
agreement includes a license...
Abzena Launches ADC and Biologics Cascade Ex-Vivo platforms Augmented With Biobank Samples
Abzena, the leading biologics target to GMP Partner Research
Organisation, has augmented its antibody drug conjugation (ADC) and biologics
(including mono and bispecific antibodies)...
